This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Usana Health Sciences Inc (USNA)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 76.64M 79.02M 66.43M 50.75M
Operating Gains/Losses 46.00K -16.00K -36.00K 45.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 0.00 0.00 0.00 0.00
(Increase) Decrease in Inventories 1.10M -11.78M 1.37M -3.21M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -1.34M 2.79M -985.00K 1.50M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 29.79M 27.33M 12.58M -382.00K
Other Non-Cash Items -5.03M 158.00K 6.85M 10.50M
Net Cash From Continuing Operations 105.19M 98.89M 92.81M 70.11M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 105.19M 98.89M 92.81M 70.11M
Sale of Property, Plant & Equipment 10.00K 47.00K 154.00K 34.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -20.42M -8.05M -8.43M -10.64M
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -4.50M -4.94M 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -16.27M -21.59M -8.28M -10.61M
Issuance of Debt 30.00M 0.00 1.85M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 10.97M 454.00K 309.00K 39.00K
Repayment of Long-Term Debt -30.00M 0.00 -1.85M 0.00
Repurchase of Capital Stock -138.82M -18.09M -68.29M -33.46M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 14.83M 7.47M 3.44M 48.00K
Net Cash From Financing Activities -113.02M -10.16M -64.54M -33.37M
Effect of Exchange Rate Changes -2.12M -635.00K 501.00K 4.00K
Net Change in Cash & Cash Equivalents -26.22M 66.50M 20.49M 26.13M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

USNA Usana Health Sciences Inc

Chart of USNA

Analysts Ratings for USNA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

USNA Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs